- Location
lung cancer patients
"-
Green LED Glasses Been Developed to Improve Sleep Quality
Jul 6, 2015When you’re having trouble sleeping, light is the last thing you assume you need. But according to a pilot study attempting to solve insomnia among lung cancer patients led by University at Buffalo sleep researcher Grace Dean, light ...
Tags: Green LED, Improving Sleep Quality, LED
-
Diesel Fumes Related to Six Percent Lung Cancer Deaths
Dec 12, 2013A study has found diesel fumes could be responsible for as many as six per cent of all lung cancer deaths in the UK and USA. Researchers from the University of Utrecht in the Netherlands published a study that found people exposed to ...
Tags: Diesel Fumes, Lung Cancer Risk
-
The Presence of Breast Cancer Cells Indicating a Blood Test May Be Possible
Nov 18, 2013Preliminary studies identified the presence of breast cancer cells from serum biomarkers indicating a blood test may be possible, U.S. researchers say. Study leader biomedical engineer Tony Hu of Houston Methodist Research Institute in ...
-
Myplan Lung Cancer Test Was Launched by Myriad Genetics
Oct 31, 2013Myriad Genetics, a US-based molecular diagnostic company, has launched a new prognostic test, Myriad myPlan Lung Cancer, for patients diagnosed with early-stage lung adenocarcinoma. myPlan lung cancer test is an RNA expression panel of 31 ...
-
Boehringer Ingelheim Has Submitted a Marketing Authorisation Application to EMA
Oct 16, 2013Boehringer Ingelheim has submitted a marketing authorisation application to the European Medicines Agency (EMA) for the approval of its oral triple angiokinase inhibitor nintedanib. Nintedanib to be used in combination with docetaxel is ...
Tags: Boehringer Ingelheim, Lung Cancer
-
MolecularMD Has Obtained a License in Non-Small Cell Lung Cancer Patients
Jan 30, 2013MolecularMD has obtained an exclusive license to LKB1 for diagnostic, prognostic and predictive uses in non-small cell lung cancer patients. The Dana-Farber Cancer Institute, the Massachusetts General Hospital, the University of North ...
-
Lung Cancer Diagnostic Blood Test Is Developed by Epic Receives Phase II Sbir
Jan 29, 2013Epic Sciences, a developer of diagnostic tests, has received a Phase II small business innovation research (SBIR) contract from the National Cancer Institute (NCI) and the National Institutes of Health (NIH) for the development of a lung ...
Tags: lung cancer diagnostic, blood test, Epic
-
Phase II SBIR Contract to Epic Sciences for Development of Lung Cancer Blood Test
Jan 28, 2013The National Cancer Institute (NCI) and the National Institutes of Health (NIH) have announced a Phase II small business innovation research (SBIR) contract to Epic Sciences for the development of a lung cancer diagnostic blood test. The ...
-
Cancer Patients Will Be Able to Receive Modern Radiosurgery Treatments
Jan 18, 2013Cancer patients in the north-east of England will be able to receive modern radiosurgery treatments without having to travel outside the region since the Northern Centre for Cancer Care (NCCC) in Newcastle –upon-Tyne announced that it ...
Tags: Cancer patients, NCCC, TrueBeam STx, medical linear accelerators
-
Clarient Has Entered Into an Agreement for Lung Cancer From Insight Genetics
Dec 18, 2012Clarient Diagnostic Services, a GE Healthcare company, has entered into an agreement to license genomic biomarker for lung cancer from Insight Genetics. AS per the agreement, Clarient intends to develop and assess the performance ...
Tags: Lung Cancer, cooperation, medical technology
-
Astellas Pharma US Is Seeking FDA Approval
Dec 14, 2012Astellas Pharma US is seeking FDA approval for Tarceva tablets to treat non-small cell lung cancer patients (NSCLC) with tumors containing epidermal growth factor receptor (EGFR) that triggers mutations. The company submitted a ...
-
Multinational Biopharmaceutical Company Celgene Has Received US FDA Approval for Abraxane
Dec 7, 2012Multinational biopharmaceutical company Celgene has received US Food and Drug Administration (FDA) approval for Abraxane, which is aimed to treat locally advanced or metastatic non-small cell lung cancer in combination with carboplatin in ...
Tags: Abraxane, lung cancer, Multinational biopharmaceutical company Celgene
-
DBS Launched The Mosaic 360 System with a Product Offering of Novel Multiplex Kits
Dec 4, 2012Diagnostic Biosystems (DBS) has launched the Mosaic 360 System with a product offering of novel Multiplex Immunohistochemistry kits and a complementary line of optimized IHC reagents. The company introduces a portfolio of five Mosaic ...
-
Abbott Expands CE-IVD Product Labeling for Its Vysis Alk Break Apart Fish Probe Kit
Dec 4, 2012Abbott will expand the current CE-IVD product labeling for its Vysis ALK Break Apart FISH Probe Kit to allow the test to be marketed in the European Union as a companion diagnostic. The test uses Abbott's proprietary fluorescence in situ ...
Tags: Abbott, anaplastic lymphoma kinase, ALK, FISH technology
-
Pentax Introduces New EG-3270UK Endoscope During The 30th GEEW Congress in Brussels
Jul 11, 2012Pentax Medical, a provider of endoscopic products and services, has introduced new EG-3270UK endoscope during the 30th GEEW congress in Brussels, Belgium. The new endoscope uses an instrument channel to deliver the optimal balance of a ...
